Genenta Science SPA - ADRGNTA
13F holders, Q2 2024 (June 30)5holders
1new positions
1sold out
$3.07avg. 13F price*
At the end of Q2 2024, 5 institutions reported holding Genenta Science SPA - ADR (GNTA) in their 13F filings, unchanged from Q1 2024. 1 opened new positions and 1 sold out. The largest holders were AlTi Global, Inc. ($621K), Allianz SE ($289K) and Algebris (uk) Ltd. ($131K).
- Company
- Genenta Science SPA - ADR
- CUSIP
- 36870W100
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2024 → Q2 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $621K |
| Exits | 1 | $1.4M |
All 13F filers, Q1 2024 → Q2 2024: 201,140 shares bought and 385,313 shares sold, net −184,173 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 5 holders
| AlTi Global, Inc. | 0.02% | New | 200,288 | $621K |
| Allianz SE | 0.01% | No change | 93,200 | $289K |
| Algebris (uk) Ltd. | 0.04% | No change | 45,000 | $131K |
| UBS Group AG | 0.00% | Add +2078.1% | 893 | $3K |
| Morgan Stanley | 0.00% | No change | 500 | $2K |
"% of holder's portfolio" is GNTA's weight in each manager's 13F, not the share of Genenta Science SPA - ADR the manager owns.